Literature DB >> 31558509

Associations of Tobacco and Alcohol Use with Risk of Neuroendocrine Tumors of the Small Intestine in Utah.

Karen Curtin1,2, Lisa A Cannon-Albright3,2,4, James VanDerslice5, Zhe Yu2, Kimberly A Herget6, Ramya Thota7, Deborah W Neklason3,2.   

Abstract

BACKGROUND: Incidence of small-intestine neuroendocrine tumors (SINT) has been increasing in the United States over the past 40 years, with higher incidence in Utah than elsewhere. As information about how these tumors arise is limited, elucidating lifestyle factors associated with SINT in a statewide cohort could potentially identify those at risk to help mitigate their effects.
METHODS: Cases of SINT with a carcinoid histology (8240 or 8241) diagnosed in Utah from 1996 to 2014 with no prior history of cancer within 5 years (n = 433) were matched to population controls (1:10 ratio). Tobacco and alcohol exposures before case diagnosis were identified from International Classification of Diseases codes in statewide medical records and from self-reported data captured at patient encounters beginning in 1996. Multivariate logistic regression was used to estimate risk of SINT associated with tobacco and alcohol in cases compared with controls.
RESULTS: An increased risk of SINT was observed in tobacco-exposed individuals compared with unexposed [OR, 1.44; 95% confidence interval (CI), 1.11-1.86; P = 0.006]. Those who were exposed to alcohol exhibited an increased risk of SINT (OR, 1.62; 95% CI, 1.05-2.49; P = 0.03).
CONCLUSIONS: This study supports tobacco and alcohol use as risk factors for SINT, independent of family history. However, low rates of smoking and alcohol use in Utah coupled with higher rates of SINT suggest other factors may contribute to development of these tumors. IMPACT: Although tobacco and alcohol modestly contribute to risk, our study suggests in addition to greater detection of tumors, other as-of-yet undefined exposures may drive rising SINT incidence. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2019        PMID: 31558509      PMCID: PMC6961822          DOI: 10.1158/1055-9965.EPI-19-0465

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  18 in total

1.  Quantification of the familial contribution to juvenile idiopathic arthritis.

Authors:  Sampath Prahalad; Andrew S Zeft; Richard Pimentel; Bronte Clifford; Bernadette McNally; Geraldine P Mineau; Lynn B Jorde; John F Bohnsack
Journal:  Arthritis Rheum       Date:  2010-08

2.  Risk and Protective Factors for Small Intestine Neuroendocrine Tumors: A Prospective Case-Control Study.

Authors:  Maria Rinzivillo; Gabriele Capurso; Davide Campana; Nicola Fazio; Francesco Panzuto; Francesca Spada; Noemi Cicchese; Stefano Partelli; Paola Tomassetti; Massimo Falconi; Gianfranco Delle Fave
Journal:  Neuroendocrinology       Date:  2015-09-10       Impact factor: 4.914

Review 3.  The epidemiology of cancer of the small bowel.

Authors:  A I Neugut; J S Jacobson; S Suh; R Mukherjee; N Arber
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-03       Impact factor: 4.254

Review 4.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Authors:  James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

5.  Small bowel cancer: epidemiological and clinical characteristics from a population-based registry.

Authors:  J A DiSario; R W Burt; H Vargas; W P McWhorter
Journal:  Am J Gastroenterol       Date:  1994-05       Impact factor: 10.864

6.  Familial risk of small intestinal carcinoid and adenocarcinoma.

Authors:  Elham Kharazmi; Eero Pukkala; Kristina Sundquist; Kari Hemminki
Journal:  Clin Gastroenterol Hepatol       Date:  2013-03-15       Impact factor: 11.382

Review 7.  Biology and management of gastric carcinoid tumours: a review.

Authors:  Irvin M Modlin; Mark Kidd; Kevin D Lye
Journal:  Eur J Surg       Date:  2002

8.  Evidence for a heritable contribution to neuroendocrine tumors of the small intestine.

Authors:  Deborah W Neklason; James VanDerslice; Karen Curtin; Lisa A Cannon-Albright
Journal:  Endocr Relat Cancer       Date:  2015-11-24       Impact factor: 5.678

9.  Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.

Authors:  Arvind Dasari; Chan Shen; Daniel Halperin; Bo Zhao; Shouhao Zhou; Ying Xu; Tina Shih; James C Yao
Journal:  JAMA Oncol       Date:  2017-10-01       Impact factor: 31.777

10.  Trends of incidence and survival of gastrointestinal neuroendocrine tumors in the United States: a seer analysis.

Authors:  Vassiliki L Tsikitis; Betsy C Wertheim; Marlon A Guerrero
Journal:  J Cancer       Date:  2012-07-01       Impact factor: 4.207

View more
  1 in total

1.  Early life exposures associated with risk of small intestinal neuroendocrine tumors.

Authors:  James VanDerslice; Marissa C Taddie; Karen Curtin; Caroline Miller; Zhe Yu; Rachael Hemmert; Lisa A Cannon-Albright; Deborah W Neklason
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.